Website: www.kiatnakin.co.th http://www.kiatnakin.co.th/ 2 Management Discussion and Analysis (MD&A) For the first quarter ended March 31, 2020 comparing operating performance and financial position for the
position for the first quarter ended March 31, 2020 with those of 2019. This report discusses principal changes in the unreviewed consolidated financial statements. Changes in Financial Reporting Standards
. Name Position 1. Mr .Wutichai Leenabanchong Director 2. Mr .Theerachai Leenabanchong Director 3. Ms .Onchulee Lawsmithikul Director 4. Mr .Monthon Chatuwallopkul Director List of shareholders No. Name As
the director whose service of period is expired will return to their previous position. And to propose the Annual General Meeting of shareholder to consider the remuneration for the directors
director 3. Ms. Liang, Su – Jung Audit Committee and Independent director the director whose service of period is expired will return to their previous position. And to propose the Annual General Meeting of
consider the credit risk of its customers, resulting in drop in revenue in 2017. However, Thailand is currently well-position to be a medical hub of Asia, new hospitals are planned to build to serve
. Financial Analysis of the company As of March 31, 2018, the Company has financial position that changed from its financial status as of December 31, 2017. The changes are described as follows: Assets Items
the income from sales and other 68% is from the liquidation of inventory. The gross profit has thus decreased 0.93% from the same quarter of the previous year. Statement of financial position as of 31
from 1Q2017. 2. FINANCIAL POSITION The Consolidated Balance Sheet as of 31 March 2018 is summarized as follows. Assets As at 31 March 2018, the Company’s total Assets amounted to Baht 21,995.0 million